This page collects useful publications related to the fields of interest to the PediCAP project
International genomic definition of pneumococcal lineages, to contextualise disease, antibiotic resistance and vaccine impact
Published in: EBioMedicine, May 2019
The whole genome sequencing is used to study pneumococcal serotype, antibiotic resistance and invasiveness, in the context of genetic background.
Non-adherence to oral antibiotics for community paediatric pneumonia treatment in Malawi – A qualitative investigation
Published in: PlosOne, 2018
Analysis of reasons for adherence and non-adherence in children diagnosed and treated in the community with fast-breathing pneumonia in rural Malawi.
Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomised controlled Trial
Published in: BMJ Open, 2019
A randomIsed controlled Trial that aims to determine the optimal amoxicillin treatment strategies for CAP in young children in relation to efficacy and AMR.
World Society for Pediatric Infectious Diseases declaration on combating antimicrobial resistance in children
Published in: World J Pediatr, 2018
WSPID calls upon global and national leaders and decision makers to recognise the key importance of the impact of AMR in neonates and children.
Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries
Published in: Lancet Infect Dis, 2019
A review of country-level antibiotic consumption.
Published in: Paediatr Int Child Health, 2018
A review of the empirical antibiotic treatment of community-acquired pneumonia in neonates and children.
Challenges in the diagnosis of paediatric pneumonia in intervention field trials: recommendations from a pneumonia field trial working group
Published in: Lancet Respir Med, 2019
Recommendations regarding study design and implementation for pediatric pneumonia intervention trials.